During the past decade, Creticos Cancer Center at Advocate Illinois Masonic Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 15 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Creticos Cancer Center at Advocate Illinois Masonic Medical Center" #1 sponsor was "NSABP Foundation Inc" with 8 trials, followed by "Radiation Therapy Oncology Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "Sequus Pharmaceuticals" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Creticos Cancer Center at Advocate Illinois Masonic Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Creticos Cancer Center at Advocate Illinois Masonic Medical Center" are "Breast Cancer" (10 trials), "Head and Neck Cancer" (3 trials), "Prostate Cancer" (3 trials), "HIV Infections" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Creticos Cancer Center at Advocate Illinois Masonic Medical Center" in a lesser frequency.

Most popular intervention types in "Creticos Cancer Center at Advocate Illinois Masonic Medical Center" are "Drug" (22 trials), "Radiation" (10 trials), "Biological" (6 trials), "Procedure" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (5 trials), "cyclophosphamide" (5 trials), "cetuximab" (3 trials), "fluorouracil" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Creticos Cancer Center at Advocate Illinois Masonic Medical Center" are 13 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Creticos Cancer Center at Advocate Illinois Masonic Medical Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Creticos Cancer Center at Advocate Illinois Masonic Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Creticos Cancer Center at Advocate Illinois Masonic Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".